首页> 外文期刊>Psychopharmacology >Memantine, an NMDA receptor antagonist, differentially influences Go/No-Go performance and fMRI activity in individuals with and without a family history of alcoholism
【24h】

Memantine, an NMDA receptor antagonist, differentially influences Go/No-Go performance and fMRI activity in individuals with and without a family history of alcoholism

机译:美金刚胺是一种NMDA受体拮抗剂,对有无酒精中毒家族史的个体有差异地影响Go / No-Go表现和fMRI活性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Individuals with a family history of alcoholism (family history positive [FHP]) show higher alcoholism rates and are more impulsive than those without such a family history (family history negative [FHN]), possibly due to altered N-methyl-d-aspartate (NMDA) receptor function.
机译:患有酒精中毒的家族病史(家族史阳性[FHP])的人比没有家族病史的人(家族病史阴性[FHN])表现出更高的酗酒率和冲动,这可能是由于N-甲基-d-天冬氨酸的改变(NMDA)受体功能。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号